CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
ONBOARDbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04161131
NCT04161131N/ACompleted
CompareCT.gov

A Pilot of ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices for Adults With T1D

Molly Tanenbaum·interventional·Posted Nov 13, 2019·Updated Sep 13, 2022

In Brief

A clinical study evaluating ONBOARD for Type 1 Diabetes. Completed, enrolled 28 participants across 1 site.

Detailed Summary

This study will create a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers \& Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with type 1 diabetes (T1D) the skills to maximize benefit and minimize daily interference from barriers associated with continuous glucose monitoring (CGM) and increase readiness for closed loop.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 13, 2019
Enrollment StartDec 9, 2019
Primary CompletionOct 22, 2020
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 6.6 years ago

Interventions

ONBOARDbehavioral

Session 1: Overview; Overcoming Physical Barriers (experiential wear) Session 2: Managing CGM data (cognitive restructuring) Session 3: Social barriers (problem solving) Session 4: Trust in CGM (motivational interviewing, review of prior sessions)